Route 92 Medical's Monopoint Reperfusion System Studied in Pivotal SUMMIT MAX Trial
February 8, 2022—Route 92 Medical, Inc., a medical technology company focused on acute ischemic stroke intervention, announced the first patient
Source: evtoday.com